$1.68
-0.07-4%
Last update: Oct 30, 7:57 PM
Elicio Therapeutics Inc
ELTXNASDAQ
Elicio Therapeutics (ELTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.54 | $-0.47 | $-0.46 | $-0.54 |
| Actual | $-0.43 | $-0.65 | $-0.45 | $-0.60 |
| Surprise | +20.4% | -38.3% | +2.17% | -11.1% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.43 | $-0.40 | $-0.33 | $-0.34 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.43 | $-0.54 | 20.4 % |
| Q1 | May 11, 2026 | $-0.65 | $-0.47 | -38.3 % |
| Q4 | Mar 12, 2026 | $-0.45 | $-0.46 | 2.17 % |
| Q3 | Nov 13, 2025 | $-0.60 | $-0.54 | -11.1 % |
